Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF

被引:125
|
作者
Liu, FL [1 ]
Poursine-Laurent, J [1 ]
Link, DC [1 ]
机构
[1] Washington Univ, Sch Med, Div Bone Marrow Transplantat & Stem Cell Biol, Dept Internal Med, St Louis, MO 63110 USA
关键词
D O I
10.1182/blood.V95.10.3025.010k32_3025_3031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms that regulate hematopoietic progenitor cell (HPC) mobilization from the bone marrow to blood have not yet been defined, HPC mobilization by granulocyte colony-stimulating factor (G-CSF), cyclophosphamide (CY), or interleukin-8 but not flt-3 ligand is markedly impaired in G-CSF receptor-deficient (G-CSFR-deficient) mice. G-CSFR is expressed on mature hematopoietic cells, HPCs, and stromal cells, which suggests that G-CSFR signals in one or more of these cell types was required for mobilization by these agents. To define the cell type(s) responsible for G-CSF-dependent mobilization, a series of chimeric mice were generated using bone marrow transplantation. Mobilization studies in these chimeras demonstrated that expression of the G-CSFR on transplantable hematopoietic cells but not stromal cells is required for CY- or G-CSF-induced mobilization. Moreover, in irradiated mice reconstituted with both wild type and G-CSFR-deficient bone marrow cells, treatment with CY or G-CSF resulted in the equal mobilization of both types of HPCs. This result held true; for a broad spectrum of HPCs including colony-forming cells, CD34(+) lineage(-) and Sca(+) lineage- cells, and long-term culture initiating cells. Collectively, these data provide the first definitive evidence that expression of the G-CSFR on HPCs is not required for their mobilization by G-CSF and suggest a model in which G-CSFR-dependent signals act in trans to mobilize HPCs from the bone marrow, (C) 2000 by The American Society of Hematology.
引用
收藏
页码:3025 / 3031
页数:7
相关论文
共 50 条
  • [1] Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice
    Christopher, Matthew J.
    Rao, Mahil
    Liu, Fulu
    Woloszynek, Jill R.
    Link, Daniel C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (02): : 251 - 260
  • [2] Harvesting after G-CSF mobilization: Previous therapy with G-CSF decreases the number of circulating progenitor cells
    Olavarria, E
    Nevado, MI
    Estevez, L
    Prieto, E
    Roman, A
    Soto, C
    Lobo, F
    Paniagua, G
    Llorente, L
    Barbolla, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 931 - 931
  • [3] The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
    Flomenberg, N
    Devine, SM
    DiPersio, JF
    Liesveld, JL
    McCarty, JM
    Rowley, SD
    Vesole, DH
    Badel, K
    Calandra, G
    BLOOD, 2005, 106 (05) : 1867 - 1874
  • [4] Analysis of modifiers of G-CSF induced hematopoietic progenitor cell mobilization
    Geiger, H
    Daria, D
    Nattamai, K
    Szilvassy, S
    Van Zant, G
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 188 - 189
  • [5] Expression of the G-CSF Receptor in Monocytes is Sufficient to Mediate Osteoblast Suppression and HSPC Mobilization by G-CSF in Mice
    Rao, Mahil
    Christopher, Matthew
    Woloszynek, Jill
    Liu, Fulu
    Link, Daniel C.
    BLOOD, 2009, 114 (22) : 234 - 235
  • [6] POLYMORPHISM AND EXPRESSION OF G-CSF RECEPTOR AND EFFECTIVENESS OF G-CSF-INDUCED MOBILIZATION IN THE RECIPIENTS OF AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELLS
    Gebura, Katarzyna
    Butrym, Aleksandra
    Wrobel, Tomasz
    Kuliczkowski, Kazimierz
    Bogunia-Kubik, Katarzyna
    HLA, 2017, 89 (06) : 412 - 412
  • [7] G-CSF alone is superior to chemotherapy plus G-CSF for 2nd mobilization of peripheral blood progenitor cells (PBPC) after failure of adequate mobilization with chemotherapy and G-CSF
    Fraipont, V
    Sautois, B
    Baudoux, E
    Pereira, M
    Fassotte, MF
    Longrée, L
    Jerusalem, G
    Hermanne, JP
    Schaaf-Lafontaine, N
    Sondag, D
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 1999, 23 : S213 - S213
  • [8] G-CSF or not G-CSF?: That is the question
    Canales, MA
    Hernández-Navarro, F
    BONE MARROW TRANSPLANTATION, 2004, 34 (06) : 557 - 557
  • [9] G-CSF or not G-CSF? That is the question
    M A Canales
    F Hernández-Navarro
    Bone Marrow Transplantation, 2004, 34 : 557 - 557
  • [10] Plerixafor plus G-CSF (P plus G) compared with G-CSF alone (G) for hematopoietic progenitor cell (HPC) mobilization in AL amyloidosis (AL).
    Dhakal, Binod
    Strouse, Christopher Sun
    Arce-Lara, Carlos
    D'souza, Anita
    Esselman, Jean
    Eastwood, Daniel
    Pasquini, Marcelo C.
    Saber, Wael
    Drobyski, William R.
    Hari, Parameswaran
    Hamadani, Mehdi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)